<DOC>
	<DOCNO>NCT00475280</DOCNO>
	<brief_summary>This study aim consider clinical heterogeneity patient base `` geriatric assessment '' without take account real age subject . This allow physician adapt therapy accord three different group patient : frail , fit intermediate evaluate efficacy feasibility therapy adapt different category patient .</brief_summary>
	<brief_title>`` Geriatric Assessment Adapted '' Therapy Ph- ALL Elderly Patients</brief_title>
	<detailed_description>Treatment : 1 . Frail patient : - Pretreatment PDN - Induction Vinblastine PDN - Maintenance MTX , 6-MP , VBL PDN 2 . Fit patient : - Pretreatment PDN - Induction VCR , DNR PDN - Consolidation MTX , ARA-C G-CSF - Autologous transplantation - Maintenance MTX , 6-MP , VCR , PDN 3 . Intermediate patient : - Pretreatment PDN - Induction VCR , DNR PDN - Consolidation MTX , ARA-C G-CSF - A second cycle consolidation therapy - Maintenance MTX , 6-MP , VCR , PDN</detailed_description>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<criteria>Age &gt; 60 year old Cytomorphologic immunophenotypic diagnosis ALL ( FAB group except L3 immunophenotypes except SmIg+ BALL ) Signed informed consent Age &lt; = 60 year old Ph+ ALL Refuse sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>geriatric assessment adapt therapy</keyword>
	<keyword>Leukemia , Lymphoblastic , Acute</keyword>
	<keyword>Older patient</keyword>
	<keyword>&gt; 60 year old</keyword>
	<keyword>Ph negative</keyword>
</DOC>